The markets closed mixed with the Dow rising 13 points to 21,797 as residents in southern Florida evacuate ahead of Hurricane Irma. Nasdaq dropped 37 points to 6,360.
On the upside
NewLink Genetics (Nasdaq: NLNK) reported updated data from an ongoing Phase 2NLG2103 study of indoximod in combination with KEYTRUDA.
Bargain hunters lifted shares of Universal Insurance Holdings (NYSE: UVE) and XL Group (NYSE: XL).
GlaxoSmithKline (NYSE: GSK) exercised its option to license the right to research, develop and commercialize Adaptimmune Therapeutics' (Nasdaq: ADAP) NY-ESO SPEAR T-cell therapy program.
On the downside
Second quarter revenue for Tintri (Nasdaq: TNTR) missed estimates.
American Outdoor Brands (Nasdaq: AOBC) fell to a loss for the first quarter prompting the company to lower its full year earnings and revenue guidance.
Science Applications International (NYSE: SAIC) reported lower second quarter earnings and revenue that fell short of expectations.
In the broad market, declining issues outpaced advancers by a margin of 6 to 5 on the NYSE while advancers barely edged out decliners by a slim margin on Nasdaq. The broader S&P 500 lost 3 points to 2,461. Bitcoin plunged $470 to $4,130.
